DGEN — Deltagen Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$0.02m
- $0.77m
Annual income statement for Deltagen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st | 2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PRESS | PRESS | PRESS | PRESS | PRESS |
| Standards: | — | — | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.902 | 1.05 | 1.02 | 0.87 | 0.77 |
| Cost of Revenue | |||||
| Gross Profit | 0.664 | 0.711 | 0.66 | 0.77 | 0.766 |
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.75 | 1.11 | 0.91 | 0.714 | 0.816 |
| Operating Profit | -2.85 | -0.053 | 0.112 | 0.156 | -0.046 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -2.84 | -1.17 | -4.42 | 0.156 | -0.046 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.84 | -1.17 | -4.42 | 0.156 | -0.046 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.84 | -1.17 | -4.42 | 0.156 | -0.046 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -2.84 | -1.17 | -4.42 | 0.156 | -0.046 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.073 | -0.03 | -0.018 | 0.004 | -0.001 |
| Dividends per Share |